Risk of Ischemic Stroke, Hemorrhagic Stroke, Bleeding, and Death in Patients Switching from Vitamin K Antagonist to Dabigatran after an Ablation.
about
Risk of Ischemic Stroke, Hemorrhagic Stroke, Bleeding, and Death in Patients Switching from Vitamin K Antagonist to Dabigatran after an Ablation.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Risk of Ischemic Stroke, Hemor ...... Dabigatran after an Ablation.
@ast
Risk of Ischemic Stroke, Hemor ...... Dabigatran after an Ablation.
@en
type
label
Risk of Ischemic Stroke, Hemor ...... Dabigatran after an Ablation.
@ast
Risk of Ischemic Stroke, Hemor ...... Dabigatran after an Ablation.
@en
prefLabel
Risk of Ischemic Stroke, Hemor ...... Dabigatran after an Ablation.
@ast
Risk of Ischemic Stroke, Hemor ...... Dabigatran after an Ablation.
@en
P2093
P2860
P50
P1433
P1476
Risk of Ischemic Stroke, Hemor ...... Dabigatran after an Ablation.
@en
P2093
Caroline Sindet-Pedersen
Christina Ji-Young Lee
Jannik Langtved Pallisgaard
Laila Staerk
Tommi Bo Lindhardt
P2860
P304
P356
10.1371/JOURNAL.PONE.0161768
P407
P577
2016-08-25T00:00:00Z